Gene-editing platform could boost anti-cancer immune responses

Researchers have developed a new gene-editing platform that will enable safer and more effective T cell–based immunotherapies to treat cancer.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup